Investor’s Toolkit: Key Ratios for Assessing Kura Oncology Inc (KURA)’s Performance

Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Kura Oncology Inc (NASDAQ: KURA) closed the day trading at $18.16 up 1.51% from the previous closing price of $17.89. In other words, the price has increased by $1.51 from its previous closing price. On the day, 0.48 million shares were traded. KURA stock price reached its highest trading level at $18.5 during the session, while it also had its lowest trading level at $17.99.

Ratios:

For a better understanding of KURA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.94 and its Current Ratio is at 14.94. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on December 22, 2023, initiated with a Buy rating and assigned the stock a target price of $26.

On August 11, 2023, BofA Securities started tracking the stock assigning a Buy rating and target price of $31.

On July 27, 2023, Scotiabank started tracking the stock assigning a Sector Perform rating and target price of $10.50.Scotiabank initiated its Sector Perform rating on July 27, 2023, with a $10.50 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 20 ’24 when Bair Teresa Brophy sold 2,615 shares for $22.15 per share. The transaction valued at 57,916 led to the insider holds 68,979 shares of the business.

DOYLE THOMAS JAMES sold 2,318 shares of KURA for $41,262 on Jan 29 ’24. The SVP, Finance & Accounting now owns 48,093 shares after completing the transaction at $17.80 per share. On Jan 29 ’24, another insider, Bair Teresa Brophy, who serves as the Chief Legal Officer of the company, sold 2,053 shares for $17.80 each. As a result, the insider received 36,544 and left with 68,979 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KURA now has a Market Capitalization of 1391682432 and an Enterprise Value of 896205120.

Stock Price History:

Over the past 52 weeks, KURA has reached a high of $24.17, while it has fallen to a 52-week low of $7.41. The 50-Day Moving Average of the stock is -7.78%, while the 200-Day Moving Average is calculated to be -8.53%.

Shares Statistics:

Over the past 3-months, KURA traded about 584.99K shares per day on average, while over the past 10 days, KURA traded about 481890 shares per day. A total of 74.35M shares are outstanding, with a floating share count of 64.93M. Insiders hold about 15.28% of the company’s shares, while institutions hold 91.98% stake in the company. Shares short for KURA as of 1726185600 were 10754263 with a Short Ratio of 18.38, compared to 1723680000 on 10397206. Therefore, it implies a Short% of Shares Outstanding of 10754263 and a Short% of Float of 14.17.

Most Popular